Association Between Preadmission Acid Suppressive Medication Exposure and Severity of Illness in Patients Hospitalized With COVID-19

North American Alliance for the Study of Digestive Manifestations of COVID-19

Research output: Contribution to journalShort surveypeer-review

11 Scopus citations
Original languageEnglish (US)
Pages (from-to)1417-1422.e14
JournalGastroenterology
Volume160
Issue number4
DOIs
StatePublished - Mar 2021

Funding

Teldon Alford, an author and data manager for the Alliance is now employed by Emmes, a clinical research organization that conducts research in the COVID-19 space; see the Supplementary Material for the of the North American Alliance for the Study of Digestive manifestations of COVID-19. Badih Joseph Elmunzer, MD (Conceptualization: Lead; Data curation: Lead; Formal analysis: Lead; Writing D (Conceptualization: L, Bethany Wolf, PhD (Formal analysis: Lead; Methodology: Lead; Writing ad; Formal editing: Supporting), James Scheiman, MD (Writing alysis: Lead; Methodology: Lead; Writing ad; Formalht of Equal), William Tierney, MD (Writing lysis: Lead; Methodology: Lead; Writing ad; Formalht of a Equal), Jason Taylor, MD (Writing n original draft: Supporting; Writing – review & editing: Equal)

Keywords

  • COVID-19
  • Histamine 2 Receptor Antagonists
  • Proton Pump Inhibitor
  • SARS-CoV-2

ASJC Scopus subject areas

  • Gastroenterology
  • Hepatology

Cite this